Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance

Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance

Abstract This study aims to identify pathway involvement in the development of cisplatin (cis-diamminedichloroplatinum (II); CDDP) resistance in A549 lung cancer (LC) cells by utilizing advanced bioinformatics software. We developed CDDP-resistant A549 (A549/DDP) cells through prolonged incubation w...

Full description

Bibliographic Details
Main Authors:	A K M Nawshad Hossian, Fatema Tuz Zahra, Sagun Poudel, Camille F. Abshire, Paula Polk, Jone Garai, Jovanny Zabaleta, Constantinos M. Mikelis, George Mattheolabakis
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-85930-y

Similar Items

Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
by: Fatema Tuz Zahra, et al.
Published: (2021-03-01)

Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
by: George Mattheolabakis, et al.
Published: (2019-11-01)

Inhaled Cisplatin for NSCLC: Facts and Results
by: Christoforos Kosmidis, et al.
Published: (2019-04-01)

Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers
by: Sagun Poudel, et al.
Published: (2021-07-01)

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
by: Jolanta Kryczka, et al.
Published: (2021-08-01)

Comparative analysis of miRNA profile in human dendritic cells infected with respiratory syncytial virus and human metapneumovirus
by: Ma. Del Rocio Baños-Lara, et al.
Published: (2018-07-01)

Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
by: Suyash Srivastava, et al.
Published: (2020-01-01)

Nucleic Acid Delivery with α-Tocopherol-Polyethyleneimine-Polyethylene Glycol Nanocarrier System
by: Hossian AKMN, et al.
Published: (2020-09-01)

Effect of Exosomal APE1 on Sensitivity of NSCLC A549 Cells to Cisplatin
by: DAI Nan, et al.
Published: (2020-07-01)

Weekly chemotherapy with cisplatin and paclitaxel in advanced NSCLC: a phase II study
by: G. Buccheri, et al.
Published: (2016-02-01)

Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
by: Jiaqi Xu, et al.
Published: (2021-10-01)

MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development
by: Jovanny eZabaleta
Published: (2012-12-01)

Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
by: Racheal G. Akwii, et al.
Published: (2019-05-01)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
by: Lin Z, et al.
Published: (2020-08-01)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
by: Ma Y, et al.
Published: (2019-10-01)

Effect of S-1 + cisplatin and gemcitabine + cisplatin on malignant indexes in serum and tumor tissue of advanced NSCLC patients with wild-type EGFR
by: Can Chen, et al.
Published: (2016-08-01)

ATF3 as a Key Regulator of Cisplatin Cytotoxicity: Combining ATF3 Inducing Agents Enhances Cisplatin Activity in NSCLC
by: Baghai, Tabassom
Published: (2018)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
by: Yuxin Qi, et al.
Published: (2021-01-01)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
by: Al-Keilani MS, et al.
Published: (2018-10-01)

SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
by: Hong-Wei Lv, et al.
Published: (2021-06-01)

Cell death in HeLa cells upon imperatorin and cisplatin treatment Cell death in HeLa cells upon imperatorin and cisplatin treatment
by: Joanna Jakubowicz-Gil, et al.
Published: (2012-10-01)

Iduna-mediated parthanatos inhibition can protect NSCLC cells from cisplatin-induced cell death
by: Si-Ning Huang, et al.
Published: (2018)

Comparison between Vinorelbine–Carboplatin and Vinorelbine–Cisplatin in Stage III–IV EGFR Mutations-Negative NSCLC
by: Laksmi Wulandari, et al.
Published: (2021-08-01)

Phase II study of Gemcitabine and Cisplatin Regimen in Advanced Non-Small Cell Lung Cancer (NSCLC).
by: M Hoseinzadeh Mollayosefy, et al.
Published: (2005-06-01)

Phase II study of Gemcitabine and Cisplatin Regimen in Advanced Non-Small Cell Lung Cancer (NSCLC).
by: Hoseinzadeh Mollayosefy M, et al.
Published: (2005-07-01)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
by: Zang S, et al.
Published: (2019-09-01)

MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.
by: Zeyong Jiang, et al.
Published: (2014-01-01)

Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
by: Lei Shang, et al.
Published: (2019-04-01)

Evaluation of the feasibility of intrapancreatic delivery of drug-loaded microparticles via EUS-guided fine needle injection using a swine model
by: Jennifer Caceres, et al.
Published: (2019-08-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.
by: Eva M Galan-Moya, et al.
Published: (2011-01-01)

Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
by: Nikaedo Sueli M, et al.
Published: (2004-09-01)

Expression of Concern: miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC.
by: PLOS ONE Editors
Published: (2019-01-01)

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
by: Ida Kappel Buhl, et al.
Published: (2018-01-01)

Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
by: Wang H, et al.
Published: (2021-04-01)

Growth and advanced characterization of solution-derived nanoscale La Sr MnO heteroepitaxial 0.7 0.3 3 systems
by: Zabaleta Llorens, Jone
Published: (2012)

Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
by: Yu Zhang, et al.
Published: (2017-07-01)

Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway
by: Baishen Chen, et al.
Published: (2019-01-01)

The Study of NSCLC Cell Response and the Drug-Drug Interaction upon EGFR-TKI Small Molecular Treatment
by: Wang, Hsian-Yu, et al.
Published: (2017)

Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin
by: Lucie Pešková, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_uj55ltbqvr609nrjfn07k2t6ao